| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.9M | -16.7% |
| Cost of Revenue | $3.3M | -30.2% |
| Gross Profit | $6.7M | -7.9% |
| R&D Expense | $983K | -20.8% |
| SG&A Expense | $8.5M | -6.2% |
| Operating Income | -$15.3M | -121.9% |
| Pre-tax Income | -$14.9M | -119.0% |
| Net Income | -$14.6M | -110.1% |
| EPS (Basic) | -$11.66 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.4M | -8.3% |
| Accounts Receivable | $14K | -96.6% |
| Inventory | $1.2M | -32.5% |
| Current Assets | $8.0M | -15.6% |
| Total Assets | $17.0M | -33.6% |
| Current Liabilities | $2.1M | -14.9% |
| Total Liabilities | $2.1M | -26.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.3M | -19.6% |
| Investing Cash Flow | -$1.4M | -5.0% |
| Financing Cash Flow | $5.0M | +1783.3% |
| -1434.2% |
| EPS (Diluted) | -$11.66 | -1434.2% |
| Stockholders' Equity |
| $13.1M |
| -37.5% |